College of Acupuncture and Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Sichuan, China.
Medicine (Baltimore). 2022 Mar 4;101(9):e29019. doi: 10.1097/MD.0000000000029019.
Poststroke cognitive impairment (PSCI) is often secondary to poststroke, which is common in stroke patients, induced difficulty in rehabilitation and seriously affects their quality of life. Currently, effective treatments are still limited. Researches show that acupuncture combined with traditional Chinese medicine (TCM) has a good effect on PSCI. However, there is no consistent conclusion at present. Therefore, THE purpose of this study is to assess the effectiveness and safety of acupuncture combined with TCM in the treatment of PSCI.
We will search the following databases from inception to January, 2022: the Cochrane Library, PubMed, Embase, Medline, Web of Science, China National Knowledge Infrastructure, China Biology Medicine, Wan Fang data, and the Chinese Science and Technology Periodical Database. All randomized controlled trials eligible for acupuncture combined with TCM for PSCI will be included in this study. Study selection, data extraction, and quality assessment will be performed by 2 reviewers independently. Bias risk assessment and data synthesis will be performed using the Review Manager software (RevMan, version 5.3) and R (version 3.6.1) software.
We will synthesize the current studies to evaluate the effectiveness and safety of acupuncture combined with TCM in the treatment of PSCI.
The systematic review will provide a new paradigm for acupuncture combined with TCM in the intervention of PSCI, and further provide scientific evidence for the efficacy and safety of acupuncture combined with TCM in the treatment of PSCI.
INPLASY202220062.
卒中后认知障碍（PSCI）常继发于卒中，卒中患者常见，这会导致康复困难，并严重影响他们的生活质量。目前，有效的治疗方法仍然有限。研究表明，针刺联合中药（TCM）对 PSCI 有较好的疗效。然而，目前尚无一致的结论。因此，本研究旨在评估针刺联合 TCM 治疗 PSCI 的有效性和安全性。
我们将从建库起至 2022 年 1 月检索以下数据库： Cochrane 图书馆、PubMed、Embase、Medline、Web of Science、中国国家知识基础设施、中国生物医学文献数据库、万方数据和中国科技期刊数据库。所有针刺联合 TCM 治疗 PSCI 的随机对照试验都将纳入本研究。研究选择、数据提取和质量评估将由 2 名评审员独立进行。偏倚风险评估和数据合成将使用 Review Manager 软件（RevMan，版本 5.3）和 R（版本 3.6.1）软件进行。
我们将综合目前的研究，评估针刺联合 TCM 治疗 PSCI 的有效性和安全性。
系统评价将为针刺联合 TCM 干预 PSCI 提供新的范例，并为针刺联合 TCM 治疗 PSCI 的疗效和安全性提供科学证据。
INPLASY202220062。
